Synlait Milk Lifts Full-Year FY26 Performance with Second-Half Recovery

Synlait Milk’s second-half rebound narrows losses but full-year net loss remains substantial.

What the company is saying

Synlait Milk frames its 2026 full-year results as a story of operational recovery, highlighting a sharp turnaround in the second half. The company emphasizes that reported EBITDA swung from a NZ$34.7 million loss in the first half to a NZ$42.8 million profit in the second half, and net profit after tax improved from a NZ$80.6 million loss to a NZ$5.2 million profit over the same period. Management, led by acting CEO Leon Fung, attributes this improvement to enhanced operational stability, completed 17 major projects during the winter shutdown, and strengthened leadership and quality controls. The announcement acknowledges that the first half was weighed down by manufacturing disruption, production plan changes, and higher costs, especially in Advanced Nutrition and Ingredients. The company stresses that while progress is evident, recovery is ongoing, and future plans focus on diversifying revenue streams to build resilience. The tone is cautiously optimistic, with a clear message that challenges remain and there is no complacency.

What the data suggests

The disclosed figures show Synlait’s full-year revenue at NZ$1.94 billion, with reported EBITDA of NZ$8.1 million and underlying EBITDA of NZ$46.3 million. Despite a second-half recovery, the company posted a full-year reported net profit after tax loss of NZ$75.4 million. Segment performance was mixed: Advanced Nutrition revenue fell 1% and gross profit plunged 78%, driven by manufacturing inefficiencies, stricter quality controls, and lower lactoferrin output. Ingredients revenue dropped 15% to NZ$574.7 million, with gross profit down 26% to NZ$9.7 million. In contrast, Consumer revenue rose 32% and gross profit increased 32% to NZ$51.7 million, while Foodservice revenue surged 62% and delivered its first full year of positive gross profit at NZ$11 million. The data confirms that operational improvements in the second half partially offset earlier setbacks, but the scale of the full-year loss underscores persistent structural and cost challenges. The company’s explanation for segment declines is consistent with the numbers, but margin pressures remain significant in key business lines.

Analysis

The announcement is largely factual, with the majority of claims supported by detailed financial and operational data for both the first and second halves of the year. The company discloses realised improvements in EBITDA and net profit after tax, as well as segmental revenue and gross profit figures, which substantiate the narrative of a stronger second half. While there is some positive framing around 'making progress' and 'recovery continues,' these are minor and do not overshadow the quantitative disclosures. The only forward-looking statements are general intentions to rebuild and diversify, which are not presented as imminent or guaranteed outcomes. There is no evidence of exaggerated tone or narrative inflation, and the capital outlay (17 major projects) is already completed, with no claims of future, uncertain returns tied to new spending. The absence of a full-year net profit (still a loss) and the lack of free cash flow or margin detail cap the signal at weak_positive.

Risk flags

• ●Despite a strong second half, Synlait ended the year with a NZ$75.4 million net loss after tax, highlighting ongoing financial vulnerability. This sustained loss limits the company’s flexibility to absorb further shocks or invest aggressively in growth.
• ●Advanced Nutrition and Ingredients segments both experienced significant declines, with Advanced Nutrition gross profit down 78% and Ingredients gross profit down 26%. Continued underperformance in these core areas could undermine future recovery if operational issues are not fully resolved.
• ●The company’s recovery narrative relies heavily on recent operational improvements and project completions, but there is no evidence yet of consistent, full-year profitability. Execution risk remains if cost controls or quality initiatives falter or if market conditions deteriorate.
• ●Management turnover is implied by the presence of an acting CEO, Leon Fung, which may signal leadership transition risk and potential uncertainty around long-term strategic direction.

Bottom line

Synlait Milk’s 2026 results show a marked operational and financial rebound in the second half, but the company remains loss-making on a full-year basis with a NZ$75.4 million net loss after tax. Segment data reveals deep challenges in Advanced Nutrition and Ingredients, partially offset by strong growth in Consumer and Foodservice. Management’s narrative of recovery is supported by improved second-half numbers and the completion of 17 major projects, but the absence of sustained profitability and ongoing margin pressures in key segments temper the outlook. Investors should focus on whether Synlait can deliver consistent, full-year profits and margin recovery, especially in its largest business lines. The most important takeaway is that while the turnaround is real, the company’s path to durable profitability is not yet assured.

Announcement summary

(ASX:SM1) Synlait Milk reported a significant improvement in operational and financial performance in the second half of the 12 months to 31 July 2026, following a challenging first half. Reported EBITDA shifted from a NZ$34.7 million loss in the first half to a NZ$42.8 million profit in the second half. Reported net profit after tax improved from a NZ$80.6 million loss in the first half to a NZ$5.2 million profit in the second half. For the full year, Synlait achieved revenue of NZ$1.94 billion. Full year reported EBITDA was NZ$8.1 million, and underlying EBITDA was NZ$46.3 million. The company recorded a reported net profit after tax loss of NZ$75.4 million for the year. Synlait completed 17 major projects during its winter shutdown, strengthened frontline leadership and maintenance practices, and introduced additional quality controls to stabilise operations at Dunsandel. Advanced Nutrition revenue declined 1% and gross profit dropped 78% due to manufacturing inefficiencies, enhanced quality controls, and lower lactoferrin production. Ingredients revenue decreased 15% to NZ$574.7 million, with gross profit falling 26% to NZ$9.7 million. Consumer revenue increased 32%, and gross profit rose 32% to NZ$51.7 million. Foodservice revenue climbed 62%, delivering its first full year of positive gross profit at NZ$11 million, driven by volume growth, improved pricing, and expansion in overseas markets. Acting chief executive officer Leon Fung stated that Synlait is making progress and is focused on ensuring the recovery continues, with plans to rebuild the company with diversified revenue streams for greater resilience.

Disagree with this article?